Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

1(33%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_3

33%

Ph not_applicable

33%

Ph phase_4

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 3Large-scale testing

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Other(1)

Detailed Status

Recruiting1

Completed1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 31 (33.3%)

Phase 41 (33.3%)

N/A1 (33.3%)

Trials by Status

recruiting133%

completed133%

unknown133%

Recent Activity

1 active trials

Showing 3 of 3

recruitingphase_4

Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone

NCT06690164

completedphase_3

Pharmaco-metabolomic Effects of Statins: METASTATINE

NCT03837925

unknownnot_applicable

Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease

NCT03355027

Clinical Trials (3)

Showing 3 of 3 trials

NCT06690164Phase 4

Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone

Recruiting

NCT03837925Phase 3

Pharmaco-metabolomic Effects of Statins: METASTATINE

Completed

NCT03355027Not Applicable

Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease

Unknown

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3